论文部分内容阅读
目的:观察奥扎格雷钠治疗急性脑梗死的疗效。方法:选择诊断明确的急性脑梗死患者118例,奥扎格雷钠治疗组58例,给予奥扎格雷钠80 mg加入0.9%氯化钠注射液250 ml静脉滴注,2次/d,对照组60例,给予丹参注射液20 ml加入0.9%氯化钠注射液250 ml,1次/d。治疗2周后,按临床神经功能缺损程度评分标准,进行临床疗效评定。结果:治疗组总有效率和显效率与对照组比较差异有统计学意义(P<0.05),且无明显不良反应。结论:奥扎格雷钠治疗急性脑梗死是一种安全有效的方法。
Objective: To observe the efficacy of ozagrel sodium in the treatment of acute cerebral infarction. Methods: 118 patients with acute cerebral infarction and 58 patients with ozagrel sodium were enrolled in this study. Ozagrel sodium 80 mg was given intravenously in 0.9% sodium chloride 250 ml intravenously twice a day, Sixty patients were given Danshen injection 20 ml 0.9% sodium chloride injection 250 ml once a day. After 2 weeks of treatment, according to the clinical neurological deficit score standards, clinical efficacy evaluation. Results: The total effective rate and markedly effective rate in the treatment group were significantly different from those in the control group (P <0.05), and no obvious adverse reactions were found. Conclusion: Ozagrel sodium in the treatment of acute cerebral infarction is a safe and effective method.